Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Transactions

Kevin Feeley, CFO of GeneDx Holdings Corp., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

Summary

• On June 9, 2024, Kevin Feeley, CFO of GeneDx Holdings Corp., acquired 2,462 shares of Class A Common Stock at $0 via Restricted Stock Units (RSUs).
• Also on June 9, 2024, 2,462 Restricted Stock Units were disposed of.
• On June 10, 2024, Feeley disposed of 895 shares of Class A Common Stock at a price of $24.92.
• Following these transactions, Feeley beneficially owns 32,858 shares of Class A Common Stock and 24,621 Restricted Stock Units.
• The sales reported on Form 4 represent shares sold by Feeley to cover tax withholding obligations related to the vesting and settlement of RSUs.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about ownership changes.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel within GeneDx Holdings Corp.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the sales are primarily to cover tax obligations and are not indicative of a change in the executive's long-term outlook on the company.

Key Dates